Vaporised cannabis, driving and cognitio
- Conditions
- This study will look at the differential effects of variations in cannabis chemovars on driving ability and cognitionTherapeutic area: Not possible to specify
- Registration Number
- EUCTR2018-003945-40-NL
- Lead Sponsor
- Maastricht University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 20
•Occasional cannabis users (>10 lifetime exposures and <2x/week in the last 12 months)
•Age between 20-50
•Good physical health as determined by medical examination and laboratory analysis
•Absence of any major medical, endocrine and neurological condition
•Normal weight, body mass index (weight/height2) between 20 and 28 kg/m2
•In possession of a valid driver license with at least 2 years driving experience (having driven > 3000 km/yr)
•Written Informed Consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 20
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
•History of drug abuse (other than the use of cannabis) or addiction (determined by the medical questionnaire, drug questionnaire and medical examination)
•Pregnancy or lactation (pregnancy test, if needed)
•Hypertension (diastolic> 90; systolic> 140)
•Current or history of psychiatric disorder (determined by the medical questionnaire and medical examination)
•Liver dysfunction
•Use of medications that may impact upon driving ability (e.g. mood stabilisers, sedatives)
•Any serious prior adverse response to cannabis
•History of cardiac dysfunctions (e.g. arrhythmia, ischemic heart disease)
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method